Does Semaglutide Reduce Kidney Disease Events on Top of SGLT2 Inhibitors in Patients with CKD and T2D?
- PMID: 38838981
- DOI: 10.1016/j.cardfail.2024.05.006
Does Semaglutide Reduce Kidney Disease Events on Top of SGLT2 Inhibitors in Patients with CKD and T2D?
Keywords: Semaglutide, SGLT2 inhibitor, type 2 diabetes; chronic kidney disease.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
